MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Available-for-sale debt securities$1,049,700K Accounts receivable$768,100K Cash and cashequivalents$266,500K Prepaid expenses$224,800K Inventory$64,500K Other current assets$62,500K Total current assets$2,436,100K Available-for-sale debt securities$1,331,000K Right-of-use assets$447,100K Deferred tax assets$381,400K Equity investments$146,100K Property and equipment,net$90,900K Other noncurrentassets$73,600K Total assets$4,906,200K Total liabilities andstockholders equity$4,906,200K Total stockholdersequity$3,407,400K Total liabilities$1,498,800K Additional paid-in capital$2,817,300K Retained earnings$589,600K Accumulated othercomprehensive income$400K Total currentliabilities$831,700K Noncurrent operating leaseliabilities$406,200K Other noncurrentliabilities$260,900K Accounts payable andaccrued liabilities$773,000K Other currentliabilities$58,700K
Balance Sheet

NEUROCRINE BIOSCIENCES INC (NBIX)

NEUROCRINE BIOSCIENCES INC (NBIX)

source: myfinsight.com